Denna webbsida är endast avsedd för läkare och sjukvårdspersonal med förskrivningsrätt.

Landscape of CDK4/6 inhibitors Clinical experience, efficacy and side effect management

Härmed inbjuds du till att delta vid ett direktsänt och interaktivt webinar

We are pleased to invite you to Lilly Academy, an interactive education on metastatic breast cancer. The focus for this session will be a look into CDK4/6 inhibitors – discussing clinical experience, efficacy and side effect management. All participants are welcome to submit questions prior to the lecture through your local contact from Lilly or via the chat function during the meeting. The meeting will be held in English.

For more information and registration click here

Liknande poster

Verzenios EU-godkänt för adjuvant behandling av HR+/HER2-, node positiv, bröstcancer

Optimizing Treatment for ER+/HER2- mBC patients with aggressive disease

Continuing Advances in mBC – Not all CDK4&6i are the same